Drugs / ND-420
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02017600 | Aug 2013 → Dec 2014 | esophageal squamous cell carcinoma | Nang Kuang Pharmaceutical Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ND-420 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02017600 ↗ |
| Known as | ND-420(Nangkuang) | “ND-420(Nangkuang)” NCT02017600 ↗ |